4.7 Article

Risk of coronary artery disease according to glucose abnormality status and prior coronary artery disease in Japanese men

期刊

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2019.153991

关键词

Coronary artery disease; Glucose abnormality status; Clinical epidemiology; Cardiovascular disease; Risk factors

资金

  1. Japan Society for the Promotion of Science [18K17897]
  2. Grants-in-Aid for Scientific Research [18K17897] Funding Source: KAKEN

向作者/读者索取更多资源

Objective: Although glucose abnormality status (GAS), prior coronary artery disease (CAD), and other traditional risk factors affect the incidence of subsequent CAD, their impact in the same cohort has been scantly studied. Research design and methods: We analyzed data from a nationwide claims database in Japan that was accumulated during 2008-2016 involving 138,162 men aged 18-72 years. Participants were classified as having normoglycemia, borderline glycemia, or diabetes mellitus (DM) with prior CAD (CAD+) or without prior CAD (CAD-). Cox regression model identified variables related to the incidence of CAD. Results: Among CAD-, management of traditional risks differed from those with and without subsequent CAD events. On the other hand, such differences were weaker in borderline glycemia and DM CAD+, and the influence of traditional risk factors on subsequent CAD was not observed. Cox regression model showed that borderline glycemia and DM confer approximately 1.2- and 2.8-fold excess risks of CAD, respectively, compared with CAD- with normoglycemia. CAD+ confers approximately a 5- to 8-fold increased risk. The impacts of DM and prior CAD additively reached a hazard ratio (HR) of 15.74 (95% confidence interval [CI]: 11.82-21.00). However, the HR in those with borderline glycemia and CAD+ was 7.20 (95% CI: 5.01-10.34), which was not different from those with normoglycemia and CAD+. Conclusion: Control status of traditional risk factors and impact on subsequent CAD differ among categories of glycemic status with and without prior CAD. Individualizing treatment strategies is needed in consideration of risk factors, such as GAS and CAD+. (C) 2019 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Relationship between changes in blood pressure from summer to winter and estimated 24-hour salt excretion using spot urine: the Niigata Wellness Study

Kiminori Kato, Tomoaki Ishigami, Takashi Kobayashi, Minoru Tahiro, Shigemi Tashiro, Takaho Yamada, Midori Iwanaga, Satoru Kodama, Kazuya Fujihara, Koji Sato, Hirohito Sone

Summary: Salt excretion using spot urine (e-NaCl) is a convenient method to determine salt intake. In this study, e-NaCl was measured during health checkups and compared with seasonal changes in blood pressure. The results showed that e-NaCl decreased in summer, possibly due to reduced burden on the kidneys for salt excretion caused by sweating, which may be related to decreases in blood pressure.

HYPERTENSION RESEARCH (2023)

Article Peripheral Vascular Disease

Combined effects of blood pressure and glycemic status on risk of heart failure: a population-based study

Ayako Kobayashi, Kazuya Fujihara, Mayuko Harada Yamada, Takaaki Sato, Yuta Yaguchi, Masaru Kitazawa, Yasuhiro Matsubayashi, Midori Iwanaga, Takaho Yamada, Satoru Kodama, Hirohito Sone

Summary: This study investigated the combined effects of blood pressure and glycemic status on the risk of heart failure using a Japanese claims database. The results showed that the relationship between blood pressure and heart failure risk weakened with worsening of glucose metabolism. In patients with diabetes, comprehensive management of risk factors other than blood pressure may be essential to prevent heart failure.

JOURNAL OF HYPERTENSION (2023)

Review Medicine, General & Internal

Network meta-analysis of glucose-lowering drug treatment regimens with the potential risk of hypoglycemia in patients with type 2 diabetes mellitus in terms of glycemic control and severe hypoglycemia

Satoru Kodama, Kazuya Fujihara, Hajime Ishiguro, Yasuhiro Matsubayashi, Masaru Kitazawa, Midori Iwanaga, Takaho Yamada, Kiminori Kato, Yoshimi Nakagawa, Shiro Tanaka, Hitoshi Shimano, Hirohito Sone

Summary: This network meta-analysis aimed to find optimal glucose-lowering drug treatment regimens in terms of glycemic control and hypoglycemia risk for patients with type 2 diabetes. The use of insulin and non-insulin glucose-lowering agents showed better glycemic control and lower risk of hypoglycemia. Certain combinations of insulin and non-insulin agents were identified as high-efficacy and relatively high-efficacy options for glycemic control. Clinicians should consider appropriate combinations of non-insulin agents to reduce hypoglycemia risk before switching to insulin therapies and be willing to add non-insulin agents to insulin for further improvement in glycemic control.

JOURNAL OF INVESTIGATIVE MEDICINE (2023)

Article Endocrinology & Metabolism

Risk of fetal undergrowth in the management of gestational diabetes mellitus in Japan

Maki Kawasaki, Naoko Arata, Takashi Sugiyama, Tatsumi Moriya, Atsuo Itakuda, Ichiro Yasuhi, Yasuko Uchigata, Eiji Kawasaki, Hirohito Sone, Yuji Hiramatsu

Summary: This study aimed to establish a prospective registry system for gestational diabetes mellitus (GDM) in Japan and to clarify the actual status of GDM according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. The results showed that the risk of low birth weight (LBW) and small-for-gestational age in the GDM group was significantly higher than in the normal glucose tolerance (NGT) group.

JOURNAL OF DIABETES INVESTIGATION (2023)

Article Sport Sciences

Utility of a Physical Fitness Score in Screening for Chronic Diseases

Takaaki Sato, Kazuya Fujihara, Mayuko Harada Yamada, Kaori Chou, Yuta Yaguchi, Masaru Kitazawa, Hajime Ishiguro, Taeko Osawa, Takaho Yamada, Satoru Kodama, Kiminori Kato, Hirohito Sone

Summary: A new Physical Score (PS) was developed and its association with metabolic diseases among Japanese individuals was elucidated. The PS was calculated based on physical fitness indicators and showed a significant association with an increased risk of metabolic diseases, especially metabolic syndrome. The PS was found to be a useful and simple non-invasive tool for screening Japanese people for metabolic diseases.

JOURNAL OF SPORTS SCIENCE AND MEDICINE (2023)

Article Endocrinology & Metabolism

Recent updates in factors associated with incidence and screening of diabetic eye disease

Hirohito Sone

JOURNAL OF DIABETES INVESTIGATION (2023)

Review Endocrinology & Metabolism

Machine Learning Approach to Drug Treatment Strategy for Diabetes Care

Kazuya Fujihara, Hirohito Sone

Summary: Globally, the number of people with diabetes mellitus has increased by four times in the past 30 years, and approximately one in 11 adults worldwide have diabetes mellitus. Managing blood glucose levels is crucial for diabetes care due to its impact on the quality of life and mortality rates of the patients. Various classes of antihyperglycemic drugs are available, but the application of clinical trial results to actual clinical practice is challenging. Machine learning approaches in drug treatment strategies for diabetes care have been slow to be adopted.

DIABETES & METABOLISM JOURNAL (2023)

Article Public, Environmental & Occupational Health

Machine learning approach to predict body weight in adults

Kazuya Fujihara, Mayuko Yamada Harada, Chika Horikawa, Midori Iwanaga, Hirofumi Tanaka, Hitoshi Nomura, Yasuharu Sui, Kyouhei Tanabe, Takaho Yamada, Satoru Kodama, Kiminori Kato, Hirohito Sone

Summary: This study developed a machine learning model to predict weight change over three years. It found that lifestyle had a significant impact on weight in individuals with high BMI and in young people. The model showed comparable accuracy to multiple regression, suggesting its potential for personalized weight management.

FRONTIERS IN PUBLIC HEALTH (2023)

Correction Nutrition & Dietetics

Citrate synthase insufficiency leads to specific metabolic adaptations in the heart and skeletal muscles upon low-carbohydrate diet feeding in mice(vol 9, 925908, 2022)

Kanako Sumi, Yuiko Hatanaka, Reina Takahashi, Naoko Wada, Chihiro Ono, Yuri Sakamoto, Hirohito Sone, Kaoruko Iida

FRONTIERS IN NUTRITION (2023)

Article Endocrinology & Metabolism

Relationship between the magnitude of body mass index reductions and remission in patients with type 2 diabetes in real world settings: Analysis of nationwide patient registry in Japan (JDDM74)

Kazuya Fujihara, Laymon Khin, Koshiro Murai, Yurie Yamazaki, Kahori Tsuruoka, Noriko Yagyuda, Katsuya Yamazaki, Hiroshi Maegawa, Shiro Tanaka, Satoru Kodama, Hirohito Sone, DDM Study Grp

Summary: This study found an association between the magnitude of weight loss and the incidence of remission in patients with diabetes. Significant weight loss is required, with at least 10% reduction, to achieve a 10% remission rate in clinical settings.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Reduced incidence of cardiovascular disease in patients with type 2 diabetes through the integrated improvement of diabetes care by comparing two prospective observational cohorts in real-world clinical practice (JDDM 72)

Hiroki Yokoyama, Shin-ichi Araki, Koichi Kawai, Katsuya Yamazaki, Osamu Tomonaga, Hajime Maeda, Masafumi Ohtaki, Hiromi Obata, Hirohito Sone, Daijiro Kabata, Ayumi Shintani, Hiroshi Maegawa, JDDM Study Group

Summary: This study aimed to investigate the reduction in all-cause mortality and cardiovascular disease morbidity in type 2 diabetes patients over the past decade in real-world practice. The results showed a significant reduction in cardiovascular disease in the recent cohort, implying the impact of treatment advances.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Endocrinology & Metabolism

Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial

Masaru Kitazawa, Yasunaga Takeda, Mariko Hatta, Chika Horikawa, Takaaki Sato, Taeko Osawa, Masahiro Ishizawa, Hiroshi Suzuki, Yasuhiro Matsubayashi, Kazuya Fujihara, Takaho Yamada, Hirohito Sone

Summary: Intervention with a smartphone app and intermittently scanned continuous glucose monitoring can improve glycemic control and lead to decreased carbohydrate intake and weight loss.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Meeting Abstract Peripheral Vascular Disease

PREDICTION AND PREVENTION OF THE ONSET OF HYPERTENSION FROM THE VIEWPOINT OF ESTIMATED 24-HOUR SALT EXCRETION AND PHYSICAL FITNESS TEST

Kiminori Kato, Tomoaki Ishigami, Hirohito Sone

JOURNAL OF HYPERTENSION (2023)

Article Primary Health Care

Fast walking and physical activity are independent contributors to improved physical function

Haruka Shiozaki, Kazuya Fujihara, Mayuko Yamada-Harada, Masahiko Yamamoto, Yurie Mitsuma, Masaru Kitazawa, Yuta Yaguchi, Yasuhiro Matsubayashi, Midori Iwanaga, Takaho Yamada, Satoru Kodama, Hirohito Sone

Summary: This study aimed to investigate the independent associations of fast walking and habitual physical activity with the incidence of functional disability. The results showed that the absence of habitual physical activity and inability to walk fast were both significant risk factors for functional disability. Furthermore, the impact of these factors on disability risk varied according to age.

FAMILY PRACTICE (2023)

Article Endocrinology & Metabolism

Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation

Emilie Steinbach, Davide Masi, Agnes Ribeiro, Patricia Serradas, Tiphaine Le Roy, Karine Clement

Summary: The study of the gut microbiome is crucial for understanding and treating metabolic diseases. While research on the fecal microbiome has provided valuable insights, relying solely on this may not be enough to draw comprehensive conclusions. The microbiome in the proximal part of the small intestine may play a significant role in metabolic regulation, but further exploration is needed due to limited accessibility.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4

Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Burak Soysal, Ilaria Cosentini, Sameer Parashar, Anuvrat Sircar, Giovanni Nigita, Lalit Sehgal, Michael A. Freitas, Philip N. Tsichlis

Summary: This study reveals the important role of KDM2B in triple-negative breast cancer (TNBC). KDM2B affects cellular resistance to oxidative stress by regulating a network of genes and metabolic enzymes, in collaboration with ATF4 and MYC. Additionally, high expression of KDM2B is associated with poor prognosis in patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Statin therapy in individuals with intermediate cardiovascular risk

Joongmin Kim, Hyeongsoo Kim, Sang Hyun Park, Yura Kang, Kyungdo Han, Sang-Hak Lee

Summary: This study aimed to investigate the optimal LDL-C level after statin therapy in individuals with intermediate cardiovascular risk. The results showed that achieving LDL-C levels <120 mg/dL after statin therapy could lower the event risk.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease

Ze Chen, Li -Ping Xia, Lang Shen, Dan Xu, Yu Guo, Hui Wang

Summary: Accumulating evidence suggests that NAFLD has an intrauterine origin, with adverse prenatal environments and glucocorticoid exposure playing a crucial role in the developmental programming of fetal hepatic lipid metabolism. The offspring's glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis is programmed in utero, leading to postnatal catch-up growth and disrupted glucose and lipid metabolism, increasing susceptibility to NAFLD. Mismatch between intrauterine and postnatal environments can further disturb the programmed endocrine axes and accelerate the onset of NAFLD.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease

Fuwen Zuo, Youzhao Wang, Xinlei Xu, Ruihao Ding, Wei Tang, Yu Sun, Xiaojie Wang, Yan Zhang, Jichao Wu, Yusheng Xie, Min Liu, Ziying Wang, Fan Yi

Summary: This study investigates the role of CCDC92 in the pathogenesis of diabetic kidney disease (DKD). The expression of CCDC92 was found to increase in kidney biopsies from patients with DKD and was correlated with glomerular lipid accumulation. Animal studies further confirmed the induction of CCDC92 in the kidney, particularly in podocytes, and the podocyte-specific deletion of Ccdc92 ameliorated podocyte injury and lipid deposition. CCDC92 was shown to promote podocyte lipotoxicity through ABCA1 signaling-mediated lipid homeostasis. Therefore, CCDC92 may serve as a potential biomarker of podocyte injury in DKD and targeting CCDC92 could be an innovative therapeutic strategy for DKD patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Brown adipose tissue-derived metabolites and their role in regulating metabolism

Khanyisani Ziqubu, Phiwayinkosi Dludla, Sihle E. Mabhida, Babalwa U. Jack, Susanne Keipert, Martin Jastroch, Sithandiwe E. Mazibuko-Mbeje

Summary: The discovery and revival of brown adipose tissue (BAT) in adult humans have opened up new possibilities for treating obesity and metabolic diseases. BAT not only plays a role in generating heat, but also secretes signaling molecules known as batokines, which regulate overall metabolism. This review highlights the importance of BAT-derived metabolites in controlling thermogenesis, substrate metabolism, and other biological processes, as well as their potential to alleviate obesity and related metabolic complications.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)